MarketCapitalization News & Analysis

2 articles

Market Mood

0 Bullish2 Neutral0 Bearish
RTW Investments Acquires $192.59 Million Stake in Apellis Pharmaceuticals
EarningsNeutral3/21/2026

RTW Investments Acquires $192.59 Million Stake in Apellis Pharmaceuticals

RTW Investments has initiated a new stake in Apellis Pharmaceuticals (NASDAQ: APLS) by acquiring 7,666,764 shares worth $192.59 million, according to a February 17, 2026, SEC filing. Apellis reported a total revenue of approximately $689 million last year, with a market capitalization of $2.2 billion. The stock is currently priced at $17.21, reflecting a 29% decline over the past year, underperforming the S&P 500's 15% increase. This significant investment in Apellis, which produces treatments for rare diseases, could influence market perceptions of biotech investments.

Read More
PayPal Holdings Inc. Trading at $44.90 with P/E Ratios at 8.30 and 8.53
EarningsNeutral3/21/2026

PayPal Holdings Inc. Trading at $44.90 with P/E Ratios at 8.30 and 8.53

As of March 13, 2026, PayPal Holdings, Inc. (PYPL) shares were trading at $44.90, with a trailing P/E ratio of 8.30 and a forward P/E of 8.53. The company reported Q4 2025 revenue of $8.68 billion (+4%), total payment volume of $475 billion (+9%), and free cash flow of $2.2 billion. Following a leadership change and disappointing guidance for 2026, PayPal's share price dropped by 20%, reducing market capitalization to below $40 billion. Despite this, the company maintains strong cash flow and plans $6 billion for share repurchases in 2026, indicating potential for recovery.

Read More